This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Implied Volatility Surging for Walgreens Boots (WBA) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Walgreens Boots (WBA) stock based on the movements in the options market lately.
Stock Market News For Apr 3, 2019
by Zacks Equity Research
Wall Street closed mixed on Tuesday as investors digest weak earnings result and not so impressive economic data.
What to Expect from CVS' Q1 Earnings After Walgreens Stock Tanks
by Benjamin Rains
CVS Health (CVS) stock has been down in the dumps for years and shares have already fallen 20% in 2019 even as the broader market booms. Now, after Walgreens Boots Alliance's (WBA) massive one-day, post-earnings selloff Tuesday, it's time to see what investors should expect from CVS.
Walgreens Has Biggest One-Day Loss in 5 year: What Does This Mean For Pharmacies?
by Daniel Laboe
Walgreens Boots Alliance (WBA) dropped over 12% today taking the price down to a low of $55, the lowest the stock has traded at since 2014. WBA???s tumble was initiated by worse than expected earnings, and a full year EPS guidance adjustment which would make them flat for 2019.
Durable Goods Mixed, Walgreen's (WBA) Disappoints
by Mark Vickery
While the preliminary view on February Durable Goods Orders were better than expected, Walgreen's fiscal Q2 came in far worse.
Walgreens Boots (WBA) Q2 Earnings Lag Estimates, Margins Down
by Zacks Equity Research
A difficult macroeconomic environment and market challenges made the fiscal second quarter the toughest since the formation of Walgreens Boots Alliance (WBA).
Walgreens' Earnings & Economic Data In Focus
by Zacks Equity Research
Walgreens' Earnings & Economic Data In Focus
Durable Goods Mixed, Walgreen's (WBA) Disappoints
by Mark Vickery
While the preliminary view on February Durable Goods Orders were better than expected, Walgreen's fiscal Q2 came in far worse.
Walgreens Boots Alliance (WBA) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of -3.53% and -0.89%, respectively, for the quarter ended February 2019. Do the numbers hold clues to what lies ahead for the stock?
Marijuana Banking, IPOs & Weed Votes: Will Hemp Grow Higher?
by Nitish Marwah
Experts are of the view that the marijuana industry would generate as much as $5 billion in annual revenues over the next two years.
The Zacks Analyst Blog Highlights: Phillip Morris, Bristol-Myers, Walgreens, Sirius and Total System
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Phillip Morris, Bristol-Myers, Walgreens, Sirius and Total System
Top Research Reports for Phillip Morris, Bristol-Myers & Walgreens Boots
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Phillip Morris (PM), Bristol-Myers (BMY) and Walgreens Boots (WBA).
Can Retail Pharmacy USA Lift Walgreens' (WBA) Q2 Earnings?
by Zacks Equity Research
Widening pharmacy network, healthy prescription volumes along with contributions from Rite Aid are expected to contribute to Walgreens Boots' (WBA) top line in the fiscal second quarter.
Buy Walgreens (WBA) Stock Ahead of Q2 Earnings, Before CBD Push?
by Benjamin Rains
Shares of Walgreens Boots Alliance, Inc. (WBA) have fallen roughly 9% this year, which stands in contrast to the market's nearly 13% climb and its industry's 4.5% average gains. But is it time to buy WBA stock ahead of earnings?
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $61.92, marking a +0.37% move from the previous day.
Better Buy Amid Tech Diversification: Apple (AAPL) vs. Amazon (AMZN) Stock
by Benjamin Rains
Apple (AAPL) and Amazon (AMZN) are two of the largest companies on the planet. The tech powers have reshaped industries and changed the way millions of people function on a daily basis. But today, Apple and Amazon face possible transition periods as they try to expand their offerings to drive growth. So which stock, AAPL or AMZN, is a better buy?
Earnings Preview: Walgreens Boots Alliance (WBA) Q2 Earnings Expected to Decline
by Zacks Equity Research
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Lululemon (LULU) Stock Looks Like a Buy Heading into Q4 Earnings
by Benjamin Rains
Lululemon (LULU) shares popped over 3% Thursday heading into the release of its fourth quarter financial results, as part of its larger 2019 climb. The yoga apparel and athleisure giant's bottom-line looks set to surge as it expands its menswear business, its global reach, and more.
Walgreens Boots Alliance (WBA) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $62.79 in the latest trading session, marking a -1.54% move from the prior day.
Amazon's HSA & FSA Payment Option to Boost Pharma Initiatives
by Zacks Equity Research
Amazon (AMZN) rolls out payment options via HSA and FSA for medical purchases made on its online platform which is likely to strengthen its healthcare market presence.
What to Expect from FedEx's (FDX) Q3 Earnings
by Benjamin Rains
Let's see what to expect from FedEx's Q3 fiscal 2019 financial results, which are due out Tuesday, with larger global market conditions possibly trending in the wrong direction for the shipping and logistics powerhouse.
Buy Amazon (AMZN) Stock on Earnings Growth & E-commerce Dominance?
by Benjamin Rains
Amazon (AMZN) shares have climbed roughly 13% to start the year, which tops the market's comeback, but falls way behind fellow FAANG giants Facebook (FB) and Netflix (NFLX). Therefore, Amazon stock still rests over 17% below its 52-week high.
CVS Health Stock Jumps on Bullish Coverage: Time to Buy?
by Benjamin Rains
Shares of CVS Health (CVS) surged over 4% through mid-afternoon trading Wednesday on the back of a bullish call from Bernstein analysts. The drugstore chain is also coming off a stronger-than-expected fourth quarter. So, is now the time to buy CVS stock?
Rite Aid (RAD) Plans 400 Job Cuts, Stock Up on Restructuring
by Zacks Equity Research
Rite Aid (RAD) announces leadership transition and organizational revamping in a bid to better align its operations and minimize costs.
Stock Market News For Mar 8, 2019
by Zacks Equity Research
Benchmarks closed in the red for the fourth straight session after ECB reduced its growth forecast for the eurozone economy.